The industry shaping agenda

We know that attending a virtual event for an entire day is not realistic for most people, so we’re reinventing the format rule book in an effort to maximize your time and elevate your learning experience. We’ve designed the agenda as learning modules, with 2 hour segments of thematically-linked firesides, panels and case-studies.

Click on the module below you’d like to learn more about, to get a detailed pop-up that includes; session information, times, and speakers.

 
AM
10:00-12:00pm CET
PM
12:30-2:30pm CET
3:00-4:00pm CET

You can also see the full agenda for each audience below. Click the audience you would like to learn more about and begin scrolling

Opening Keynote Themes and Speakers

Overview:The future of European Healthcare

  • Shape the European healthcare system of the future through collaboration to align stakeholders around patient value and ensure access for future pharma innovation
  • European Pharmaceutical Strategy, a review: the first step to a more sustainable health future? See the impact of key legislation on your pipelines and future products
  • Democratise healthcare through a digital revolution, fuelled by the growing power of patient-owned health data
  • Prime your future strategies for the advent of smaller, more targeted patient population groups through the blueprint of rare disease engagement strategies

Nathalie Moll Director General EFPIA

Richard Daniell EVP, Head of Europe Commercial Teva

Giles Platford President, Europe & Canada Takeda

Iskra Reic EVP, Europe & Canada AstraZeneca

Stefan Oelrich President, Pharmaceuticals Bayer

Opening Keynote Themes and Speakers

Overview:Reimagine pharma to unleash it's potential

  • Viva la commercial revolution: Why it’s now or never to redefine the nature of the pharma customer experience – or fall behind your customer’s rapidly changing needs
  • The technology of tomorrow, today: How the cocktail of AI, predictive analytics and increasing data maturity is transforming decision-making across the value chain and removing entry barriers to new therapeutic areas
  • Surpass centricity: Pioneer patient-led innovation to ensure the greatest unmet need is fulfilled with your next blockbuster
  • Scale, scale, scale! Go beyond CoEs and lighthouse projects – embed innovations across functions, regions and stakeholders

Marie-France Tschudin President, Pharmaceuticals Novartis

Catherine Mazzacco President & CEO LEO Pharma

Myrtle Potter CEO Sumitovant Biopharma

Carinne Brouillon Head, Human Pharma, Board of Managing Directors Boehringer Ingelheim

Bill Sibold EVP & Head Sanofi Genzyme

Commercial Excellence through digital transformation

10:00am – 10:15am (CET) · Tuesday, 12th October

Fireside chat:Your burning platform! Create digital - and people - transformation during commercial pharma’s industrial revolution

  • Don’t get left behind. It’s now or never to increase digital capabilities, disrupt the market, and deliver true customer centricity
  • How to clearly outline new business priorities and get buy-in from those who will be affected the most to enable accelerated transformation
  • Digital isn't a channel, it's a way of doing business. Key principles for a digitally enabled commercial model that delivers improved experiences for HCPs, payers, patients, and peers

Nikos Georgiades former SVP, Global Head of Digital Commercial Execution Novartis

10:15am – 11:00am (CET) · Tuesday, 12th October

Panel:Stop cleanin’ windows and change the foundation. ‘Cause right now you’re doing digitization not digital transformation

  • Ensure a complete customer experience by reimaging the core customer engagement model - break silos and mold cross-functional teams to deliver personalised value
  • Overcome market archetype differences to get global and local on the same page to enable savings, efficiencies, and effectiveness
  • It’s not just innovation for innovation’s sake. Understand how to identify new capabilities that hit on your business strategy and deliver for customers and patients alike

Erasmus Holm Chief Marketing Officer, Nordics MSD

Renee Amundsen Global Head, Business Innovation Merck Group

Elliot Antrobus-Holder Global Head, Omnichannel Gilead

Sierra Towers Global Head, Omnichannel Excellence Boehringer Ingelheim

Hanno Ronte Life Science and Healthcare Partner Deloitte

11:00am – 11:15am (CET) · Tuesday, 12th October

Case study:Transform your customer engagement capabilities through more educated rep engagement and effective change management

  • Communicate the strategic vision of the company so the field force commits to new ways of working and you don’t lose them along the journey
  • Empower your reps! Maximize on rep insights to co-create strategy, solve specific customer pain points, and deliver on sales goals
  • Apply new tech to field operations to enable smoother planning to execution processes that are tailored for your customer needs
  • How to use an online educational content hub to trigger rep-driven conversations with HCPs for a connected customer journey

Laia Gil Molas Commercial Operations Manager, Iberia Alexion

11:15am – 11:30am (CET) · Tuesday, 12th October

Engaging health care practitioners with purpose and impact

  • Explore why relying on high volumes of sales touchpoints doesn’t equate to patients with unmet needs receiving the right treatment, even if it yields a “positive ROI curve”
  • Ensure innovative treatments reach the patients who need them, by deploying a wider range of engagement types across the provider journey – including medical education, early diagnosis assistance, access support, patient support tools and traditional sales and marketing
  • Unlock purpose-driven engagement by taking a holistic view of each individual HCP, combining data-driven and field-based insights to select the right balance for everyone
  • Leverage technology, best practices in advanced analytics and flexible ways of working to allocate and deploy resources and capabilities dynamically every 3 – 6 months

Brent Hooper Partner, Global Leader of HCP Engagement McKinsey & Co

11:30am – 11:45am (CET) · Tuesday, 12th October

Case study:Shape your digital innovation model and capitalize on new commercial opportunities

  • Digital transformation, an enabler towards business innovation. Who needs to drive the change
  • The key success factors for customer centricity, and applying precision analytics in the commercial world
  • Lessons learnt on shaping a digital innovation commercial strategy to capture new opportunities

Mostafa Taha Chief Transformation Lead, Global Merck Group

11:45am – 12:00pm (CET) · Tuesday, 12th October

Live Q&A: Commercial Excellence through digital transformation

  • Quiz our expert speakers on their case studies and their views on the future

Laia Gil Molas Commercial Operations Manager, Iberia Alexion

Mostafa Taha Chief Transformation Lead, Global Merck Group

Digital health innovation as your competitive advantage

12:30pm – 12:45pm (CET) · Wednesday, 13th October

Fireside chat:Transformative digital technologies start with an alignment of business objectives and outcomes

  • How Almirall used the expertise of its Digital Garden entrepreneurs to create their own intrapreneurs to boost the efficiency and effectiveness of digital operations
  • Solving for the commercial imperative. Partner with start-ups as they still develop their business models, whilst also collaborating with established companies who can deliver on strategy right away

Francesca Wuttke Chief Digital Officer Almirall

12:45pm – 1:30pm (CET) · Wednesday, 13th October

Panel:From ideation to commercial success. Crack the digital innovation model

  • Explore what a solution could be by rapidly building and testing iterations. What capabilities are needed for your lighthouse projects
  • Different commercial models for your digital projects to ensure innovation doesn’t perish. How to choose between spinning the project out, creating a new BU, adding as a companion and everything in between for your project
  • Translators and Navigators. Finding internal champions and working with partners that can deliver on your vision

Chris Easton Senior Director, Global Commercial Lead, Personalized Health & Innovation, Rare Hematology Takeda

Catalina Cernica CEO Health & Happiness Foundation

Emma Hoglund Head Commercial Excellence & Digital Strategy Novartis

1:30pm – 1:45pm (CET) · Wednesday, 13th October

Case study:UCB: Develop a mature digital innovation strategy to fundamentally change care pathways for people living with severe chronic diseases

  • Case Study: How UCB is enabling earlier detection and diagnosis of patients through digital platforms and by collaborating with likeminded partners
  • Empowering your teams to capatilise on current and future patient needs through digital mindsets and culture, data, strategy and capabilities

Erik Janssen VP, Digital Transformation UCB

1:45pm – 2:00pm (CET) · Wednesday, 13th October

IQVIA Thought Leadership

Romain Lasry Senior Director, Commercial Analytics and AI/ML Innovation IQVIA

2:00pm – 2:15pm (CET) · Wednesday, 13th October

Case study:Digital health innovation through new types of transformation and partnerships

  • An assessment of fit-for-purpose technology that enables quick adoption without losing flexibility
  • How a collaborative business model enables you to fast-track development and improve digital innovation

2:15pm – 2:30pm (CET) · Wednesday, 13th October

Live Q&A: Digital innovation as your competitive advantage

  • Quiz our expert speakers on their case studies and their views on the future

Erik Janssen VP, Digital Transformation UCB

Romain Lasry Senior Director, Commercial Analytics and AI/ML Innovation IQVIA

Data centricity: for more intelligent decision-making and efficient commercial operations

10:00am – 10:15am (CET) · Thursday, 14th October

Fireside chat:The guidebook to creating a data-driven commercial organization

  • Get your entire organisation bought into the value of becoming data-driven by finding your change-makers to drive the project forward
  • Key principles to finding the technology and analytics partners that will serve your needs and create exceptional business outcomes
  • Data is alive. Understand why this isn’t a project, but a product evolution that is never finished

10:15am – 11:00am (CET) · Thursday, 14th October

Panel:Build your analytics muscle to understand customer behaviour and solve unseen pain points

  • How to successfully deploy AI, ML and advanced analytics: avoid over-complexity and inefficiency by ensuring your data management process and infrastructure are in order to enable quick adoption of new technologies
  • Educate to elevate. Ensure your data and digital literacy is of the highest caliber with a mindful approach to change management
  • Data governance: Discuss different buy or own models to find which approach will be the best fit for your purpose

Sital Kotecha Commercial Excellence Director, Growth Markets Sobi

Neelesh Shanbhag CIO & VP, Business Technology, Asia Pacific Janssen

Megan Hughes Global Head, Omnichannel Analytics Grunenthal

Morten Kruse-Jacobsen Senior Global Director, Multichannel Excellence & Operations Novo Nordisk

11:00am – 11:15am (CET) · Thursday, 14th October

Case study:Maximize the digital marketing experience with a test and learn mindset

  • Define marketing objectives and successfully roadmap your strategy
  • Install a hypothesis-based approach to all your marketing projects
  • Iterate, scale or abandon: How to successfully leverage data-driven Insights

Brett Marvel Associate Director, Digital Engagement MSD

11:15am – 11:30am (CET) · Thursday, 14th October

Sponsored Thought Leadership Opportunity

  • For more information, reach out to Maddie Sheard, Director of Business Development

11:30am – 11:45am (CET) · Thursday, 14th October

Case study:AI coming to the rescue: new technologies that enhance your business and customer intelligence capabilities

  • Create your data-organization, link multiple data sources - whether structured or unstructured - and build your predictive model to create customer behaviour profiles that can characterize new engagement opportunities
  • Scanning, characterizing available technologies and applying agile, design thinking processes to create a robust, end-to-end pilot to scale

Daniel Vertessy Business Development & Customer Intelligence Manager, DACH Region Aspen

11:45am – 12:00pm (CET) · Thursday, 14th October

Live Q&A: Data centricity: for more intelligent decision-making and efficient commercial operations

  • Quiz our expert speakers on their case studies and their views on the future

Brett Marvel Associate Director, Digital Engagement MSD

Daniel Vertessy Business Development & Customer Intelligence Manager, DACH Region Aspen

Assemble your new data and digital salesforce

10:00am – 10:15am (CET) · Monday, 18th October

Fireside chat:Hybrid engagement is here to stay – but how do you decide to what degree?

  • Develop a holistic view of your customer-facing teams for more systematic and tailored operations management
  • Less time spent travelling is your field team’s opportunity to chase more value-add opportunities
  • How to vanquish the hybrid model rep fear factor and develop your change management initiative

Ivan Blanarik Corporate SVP, Head of CardioMetabolic & Respiratory Boehringer Ingelheim

10:15am – 11:00am (CET) · Monday, 18th October

Panel:Increase your SFE with performance management approaches and capability building fit for hybrid engagement

  • Bridge the gap between your virtual and F2F capabilities through a thorough understanding of each environment’s strengths (and weaknesses)
  • More than call rates: How to change your incentives structure to reflect the shift to hybrid, customer relationship building and interactions
  • Soft selling in the virtual environment is the key to relationship building and devising common value for future success

Alexey Cherchago Head of Sales Excellence, Europe Sandoz

Chris Mann Head of Commercial Excellence, UK & Ireland Amgen

Philip McCrea Managing Director Europe Red Nucleus

11:00am – 11:15am (CET) · Monday, 18th October

Break

11:15am – 12:00pm (CET) · Monday, 18th October

Panel: Embrace technology efficiencies to increase your sales effectiveness

  • How to increase sales outputs by strengthening your business processes when implementing new technologies or rolling out to new affiliates
  • Technology disruption that aligns with your people transformation: Equip reps with digital and data expertise and see them flourish in the tech-centric environment
  • Correct use of your CRM to unlock the true-value of your customer engagement strategy

Massimiliano Siciliano Digital Solution Director Novartis

Rorik van Welij Worldwide Omni-channel Capability Lead Bristol Myers Squibb

Baptiste Mercier SVP, Commercial & Digital Marketing Services & Products BASE life science

Go-to-Market Mastery

12:30pm – 12:45pm (CET) · Tuesday, 19th October

Fireside chat:The GTM Model Evolved: A practical assessment from different markets to improve your customer engagement

  • Digital isn’t the be all and end all in a virtual world – harness omni channel to unleash new GTM models
  • Field interactions still hold the trump card to understanding customers and delivering results – an assessment on how this will evolve in the mid-term
  • Changing the way we communicate to customers requires mindset shifts for our market teams – how to bring them with us on the journey

Catherine Owen SVP, Major Markets Bristol Myers Squibb

12:45pm – 1:30pm (CET) · Tuesday, 19th October

Panel:A data and digital enabled GTM strategy for long-term business impact

  • Equal voices at the strategy meeting: Why an aligned and cross-functional GTM strategy has never been more important – and how to balance strategic priorities
  • Working backwards. Define your channel and content mix based on customer behaviours and create experiences that HCPs crave
  • The new model tenet: How to build your remote capability through technology enablement and validate your hybrid selling model to ensure reps can hit their newly defined KPIs

Patrick Markt-Niederreiter Head, Digital Excellence, Europe Daiichi Sankyo

Chetak Buaria Global Head, Customer Engagement & Channel Evolution Merck Group

Rohit Sood EVP, EVERSANA™ COMPLETE Commercialization EVERSANA

1:30pm – 1:45pm (CET) · Tuesday, 19th October

Case study:The battle of digital and virtual fatigue: Make your HCP engagement meaningful

  • Get out of the reach and frequency fight. Enhance your customer experience by putting new forms of content and value-add interactions at the heart of your HCP engagement strategy
  • Make data actionable. How to spot technological deficiencies and create a cross-company infrastructure that enables a personalised approach
  • Create a holistic customer experience through a field force strategy that balances both digital and F2F interactions, and product and disease content

Lukas Falk Director, Global Enablement and Capabilities Ipsen

1:45pm – 2:00pm (CET) · Tuesday, 19th October

Sponsored Thought Leadership Opportunity

  • For more information, reach out to Henry Payne, Director of Business Development

2:00pm – 2:15pm (CET) · Tuesday, 19th October

The evolution of the virtual go-to-market model for innovative medicines

Zhen Su Former SVP, Head of Global Oncology Business Franchise EMD Serono

2:15pm – 2:30pm (CET) · Tuesday, 19th October

Live Q&A: Go-to-Market Mastery

  • Quiz our expert speakers on their case studies and their views on the future

Lukas Falk Director, Global Enablement and Capabilities Ipsen

Establish omnichannel frameworks. Deliver a connected customer experience

10:00am – 10:15am (CET) · Wednesday, 20th October

Fireside chat:Make the move to omnichannel for a rounded customer experience and connected journey

  • Develop your roadmap to enable your omnichannel engagement strategy
  • How to ensure your messaging, content and channels are in-sync and tailored for a customer-centric strategy

Mircea Cubillos Commercial VP, Haematology, EMEA Janssen

10:15am – 11:00am (CET) · Wednesday, 20th October

Panel:Capitalize on your customer engagement strategy through omnichannel

  • Set up frameworks and processes that allow you to roll out your omnichannel strategy for new products and markets
  • Be clear on each person’s role within the strategy – from marketing to the rep orchestrator
  • Use data and insights to understand customer preferences to create experiences that address needs and drive engagement
  • How to ensure your brand strategies are aligned with the customers omnichannel journey

Denis Vallese Global Omnichannel Strategy Lead AstraZeneca

Hans Gilhuys Senior Director, Commercial Digital Gilead

Adela Schulz iEU DBT Strategy & Capabilities Lead, EU Strategy and Operations UCB

Prashant Parab SVP & GM Analytics Solutions IQVIA

11:00am – 11:15am (CET) · Wednesday, 20th October

Case study:Add value at every customer touchpoint with fully contextualized decision-making

  • Take a holistic view across your customer’s whole journey to remove disjointed communications and ensure high quality engagements
  • Finetune your internal tech stack with a CRM system optimized to meet customers needs
  • Effectively implement omnichannel strategy with new cross-functional collaboration frameworks that unlock all available insights and ensure channel interoperability

Andy Kennemer VP, Customer Experience and Digital Innovation GSK

11:15am – 11:30am (CET) · Wednesday, 20th October

TrendMD Thought Leadership

11:30am – 11:45am (CET) · Wednesday, 20th October

Case study:Enabling & empowering rep orchestration in a hybrid set-up

  • From multichannel to omnichannel management for a more strategic and data-driven approach of reps to fulfill customer needs while enhancing patient quality of care
  • Digital technologies to empower and enable reps to reach the right customer with the right channel via the right content and achieve clear-cut business goals
  • Elevation of internal omnichannel capabilities as key to increase reps´ digital maturity and ability of effectively orchestrating channels to increase customer reach and frequency, improve their experience and satisfaction

Yasemin Mehmet Senior Director, Global Customer Engagement Strategy Merck Group

Juliana Guimarães Digital Manager Merck Group

11:45am – 12:00pm (CET) · Wednesday, 20th October

Live Q&A: Establish omnichannel frameworks. Deliver a connected customer experience

  • Quiz our expert speakers on their case studies and their views on the future

Yasemin Mehmet Senior Director, Global Customer Engagement Strategy Merck Group

Juliana Guimarães Digital Manager Merck Group

Create value+ and personalised content for HCP engagement

10:00am – 10:15am (CET) · Thursday, 21st October

Fireside chat:From Push-to-Pull: How to change your content creation approach to meet new customer needs

  • Relying on push marketing is to ignore what customers want. Rebalance your promotional and non-promotional content and usher in a new generation of pharma content
  • Abandon the one-size-fits-all ship. How to identify gaps in creating personalized content and align your capabilities to customer needs

Oscar Perez Chief Marketing, Market Access & Business Development Officer Ferrer

10:15am – 11:00am (CET) · Thursday, 21st October

Panel:Execute a fit-for-multiple-environments content strategy with agile, iterative and customer tailored processes

  • Orientate your content to value by understanding customer needs and then connect the dots for a holistic customer experience
  • How to create content which is unbranded or beyond disease that can create behavior change
  • Chasing consumer brands. Is the customer experience pursuit of Amazon and Apple harming pharma’s ability to deliver on customer-centricity
  • Hear what types of content are having the greatest effect on customers right now

Vanitha S V Global Lead, Modular Content, Multichannel Excellence & Operations Novo Nordisk

Karina Morley Global Head, External Scientific Affairs AstraZeneca

Chetak Buaria Global Head, Customer Engagement & Channel Evolution Merck Group

Tim Russell Executive Vice President M3 (EU)

11:00am – 11:15am (CET) · Thursday, 21st October

Case study:Sanofi: Interactive and personalised video content that mimics the F2F rep experience

  • Receive, recognize and resonate: Understanding HCP needs for value-driven content
  • Mimic the rep-experience and deliver closed-loop messaging through interactive video experience that personalizes the content based on the customer profile

Esra Caliskan Digital Initiatives Manager Sanofi

11:15am – 11:30am (CET) · Thursday, 21st October

Building a Digital Content Factory to help accelerate content production for personalized customer engagement

Nataliya Andreychuk CEO Viseven

11:30am – 11:45am (CET) · Thursday, 21st October

Case study:How to optimise your email campaigns and create ultra-qualified outreach for reps

  • How to use your modular content system to optimise email creation and delivery. Hear the agile and iteratives processes needed to deliver engaging emails in a saturated market.
  • Unlock your CRM potential by giving the reps the tools to meet customer expectations without dictating their reach out. Options over coercion!

Andreas Dach Digital & Multi-Channel Lead, ASG Eli Lilly

11:45am – 12:00pm (CET) · Thursday, 21st October

Live Q&A: Create value+ and personalised content for HCP engagement

  • Quiz our expert speakers on their case studies and their views on the future

Esra Caliskan Digital Initiatives Manager Sanofi

Andreas Dach Digital & Multi-Channel Lead, ASG Eli Lilly

Nataliya Andreychuk CEO Viseven

The new engagement model for Medical Affairs

12:30pm – 12:45pm (CET) · Tuesday, 12th October

Fireside chat:Achieve best-in-class Medical Affairs engagement for the future

  • Deliver a personalised stakeholder experience through a multichannel strategy that balances physical and virtual interactions
  • Reimagine performance metrics across all HCP interactions to foster a physician-centric cultural transformation across your entire company and continuously recalibrate engagement models to meet evolving customer needs
  • Witness the future of Medical Affairs-led product launches that deliver a more valued HCP experience and market changing impact

Steven Hildemann EVP, Chief Medical Officer, Head of Global Medical Affairs, Patient Safety and Patient Affairs Ipsen

12:45pm – 1:30pm (CET) · Tuesday, 12th October

Panel:Medical Omnichannel Transformation: Why personalization and a digitally-enabled omni-channel strategy matters for Medical Affairs and how you can accelerate your transformation

  • Cure your physician’s virtual hangover by creating a sepmless multi-channel journey that aligns to personal preference and adds value to their daily patient interactions
  • Stand out in the crowded-digital environment by using social listening to deliver actionable insights from every interaction to inform your engagement approach
  • Optimise your physician experience through data-driven insights that personalise your dynpmic content and channel strategy

Kumaran Krishnan Director, Medical Excellence & Medical Information AstraZeneca

Robert Stevens VP, Global Head Digital Medical Affairs Novartis

Pierre Côte Transversal Project Lead, Franchise & Product Strategy Sanofi Pasteur

Moderator: Annaë Liu Medical Head, Cell & Gene, Oncology Novartis

1:30pm – 1:45pm (CET) · Tuesday, 12th October

Case study:“Hey Google, talk to Bayer Pharmaceutical.” How Bayer has enhanced HCPs access to medical information through Virtual Voice Assistant (pmI)

  • Learn how Bayer’s Medical Affairs tepm drove a cross-functional approach to pioneer innovative technology adoption inspired by analysis of physician need
  • Discover how to enhance your physician’s experience by providing faster access to relevant information through voice technology
  • See the blueprint for introducing voice technology to your company

Wagdy Youssef Senior Director US Medical Communication, Medical Information, Publication & Digital Transformation Bayer

1:45 – 2:00pm (CET) · Tuesday, 12th October

Thought leadership from Within3

2:00pm – 2:15pm (CET) · Tuesday, 12th October

Case study:Expand your reach by embracing the new-generation of scientific – how to identify and work with Digital Opinion Leaders #Trending #DOLs #MedicalAffairs

  • Learn how to identify the right DOLs to chpmpion your content and enhance your reputation across new physician demographics
  • Capture a wide range of insights from your DOLs engagement activity that can refine strategy across all channels, not just social

2:15pm – 2:30pm (CET) · Tuesday, 12th October

Live Q&A: The new engagement model for Medical Affairs

  • Quiz our expert speakers on their case studies and their views on the future

Wagdy Youssef Senior Director US Medical Communication, Medical Information, Publication & Digital Transformation Bayer

Reimagine your Medical Affairs capabilities

12:30pm – 12:45pm (CET) · Thursday, 14th October

Fireside chat:Pharma’s third pillar: Medical Affairs. Deliver value across the organisation from your seat in the boardroom

  • Embody the voice of patients and physicians within your organisation to ensure stakeholder centricy is ever-present
  • See how a separate and independent Medical Affairs function can prosper to deliver added value to the business

Harmony Garges Chief Medical Officer ViiV Healthcare

12:45pm – 1:30pm (CET) · Thursday, 14th October

Panel:Modernise Medical Affairs: The new skills, roles and capabilities needed for engagement success in the new healthcare environment

  • Create a team capable of delivering a mature multi-channel strategy by upskilling the digital competencies and soft skills of your Medical Affairs workforce
  • Achieve new levels of external value by forging new roles and responsibilities the reflect the changing image of physician need
  • Create global-to-local structures that provide support and flexibility to empower and inspire local teams to personalise their HCP engagement strategies

Christian Velten Global Head, Medical Customer Experience Roche

Joshua Corriveau Senior Director, Global Field Medical Excellence LEO Pharma

Monica de Abadal VP, Medical Excellence, Global Medical Affairs Ipsen

Moderator: Domenico Curinga Medical Head, Haematology Novartis

1:30pm – 1:45pm (CET) · Thursday, 14th October

Case study:How AstraZeneca International reimagined their Medical roles and responsibilities around changing HCP and patient needs

  • Recruit data-savvy Medical Affairs operatives to optimise your data collection and insight generation processes
  • Understand why AstraZeneca created new roles for Medical Educators and Clinical Science Liaisons to shape the primary care ecosystem and ensure the best patient experience / outcomes

Alex Bedenkov VP, Medical International & Global Health Innovation Hubs Network Head AstraZeneca

1:45pm – 2:00pm (CET) · Thursday, 14th October

Thought leadership from HCG

2:00pm – 2:15pm (CET) · Thursday, 14th October

Case study:And in the beginning… How to create a decentralised Medical Affairs organisation from scratch

  • Learn how a decentralised approach to building a Medical Affairs organisation during the pandemic has enabled faster expansion of influence across Europe
  • Integrate evidence generation into the fabric of your Medical Affairs function across clinical and commercial to deliver an agile content creation strategy

2:15pm – 2:30pm (CET) · Thursday, 14th October

Live Q&A: Reimagine your Medical Affairs capabilities

  • Quiz our expert speakers on their case studies and their views on the future

Alex Bedenkov VP, Medical International & Global Health Innovation Hubs Network Head AstraZeneca

The new face of Field Medical

10:00am – 10:15am (CET) · Tuesday, 19th October

Fireside chat:MSLs Assemble! Pharma’s new leaders for field engagement strategy in post-pandemic healthcare

  • See how your MSL team can be driving force of external engagements going forwards by demonstrating improved value by building physician trust through with higher quality content and interactions
  • Expand the influence of your field medical teams to lead physician-centric cross-functional strategy with KAMs and commercial reps

Christoph Koenen EVP, Chief Medical Officer Otsuka

10:15am – 11:00am (CET) · Tuesday, 19th October

Panel:Equip your field medical teams to flourish through the hybrid transformation

  • Find the balance of physical and virtual interactions to prevent physician fatigue and provide personalised experiences that truly deliver an MSL-led omnichannel experience
  • The digital MSL: Embed digital as a core competency of your field medical team to deliver the now essential physician-centric strategy
  • Enable your field medical team to communicate your scientific storytelling fluidly across different channels to personalise and optimise their engagements

Maja Beilmann-Schramm Director, Global Field Medical Excellence & HCP Exchange Merck Group

Mark Rees-Saunders Director, External Engagement Centre of Excellence, Established Markets Astellas

Sarah Clark Global Head, Medical Affairs and Operations, Digital Health Biogen

11:00am – 11:15am (CET) · Tuesday, 19th October

Fireside chat:Omnichannel orchestrator. The new requirement for your MSLs.

  • Empower your MSLs with data-derived insights that inform a personalised engagement strategy
  • Situate your MSL teams as the bridge between internal and external stakeholder management to deliver insights across the business

Victoria Ho Head, Medical Capabilities and Excellence, EU/ RoW Jazz

11:15am – 11:30am (CET) · Tuesday, 19th October

Empower your MSLs with the power of data

  • See how the full picture of integrated data is a game changer for your MSL team to execute strategies faster and more effectively
  • Manage your key thought leader relationships with user-level custom insights and personalize your engagements

Elke Ydens Solutions Specialist Anju Software

11:30am – 11:45am (CET) · Tuesday, 19th October

Case study:Metrics managed! How multi-channel can finally solve your performance metrics headache

  • Learn how your multi-channel engagement strategy allows you to qualitatively assess virtual engagements and refine future strategy
  • Benchmark MSL engagements across therapy and regions to spot and scale excellence

Heather Moses Country Medical Director, Oncology, UK Novartis

11:45am – 12:00pm (CET) · Tuesday, 19th October

Live Q&A: The new face of Field Medical

  • Quiz our expert speakers on their case studies and their views on the future

Heather Moses Country Medical Director, Oncology, UK Novartis

Victoria Ho Head, Medical Capabilities and Excellence, EU/ RoW Jazz

Elke Ydens Solutions Specialist Anju Software

Reimagine digital patient engagement to reach diverse patient populations and gain real-world journey understanding

12:30pm – 12:45pm (CET) · Monday, 18th October

Fireside chat:Patient engagement and pharma’s digital responsibility

  • Define pharma’s societal responsibility to set and achieve ethical standards for digital leadership
  • Understand the role of digital innovation and leadership to safeguard against data biases and ensure greater diversity and equity in patient engagement and outcomes. Understand the role of digital innovation to drive pharma towards a more diverse and equitable future
  • Deliver meaningful value to the patients, caregivers and society through economically, socially and environmentally sustainable progress towards patient-centric digital engagement

Nick Passey Commercial Digital and IT Vice President AstraZeneca

12:45pm – 1:30pm (CET) · Monday, 18th October

Panel:Employ innovations in digital engagement to empower a new generation of patient advocates

  • Explore the changing relationship between patients and HCPs and how you can fill the widening education and support gap
  • Employ innovative tools and platforms to build a multichannel engagement and educational strategy that will facilitate patient engagement across a more diverse patient audience
  • Engage a younger generation of advocates to reach new patient populations and gain more varied insights: The world of social media and health influencers
  • Give back with digital: Discover how we can repurpose our digital engagement expertise to support advocates and organizations.

Christina Kotsi Patient Engagement & Insights Project Manager Novartis

Geoff Rollason Director, Patient Experience & Service, Oncology, UK Pfizer

Mark Sterckel Senior Patient Engagement Director Ferring Pharmaceuticals

Stephanie Bach Director, UX ZS Medullan

1:30pm – 1:45pm (CET) · Monday, 18th October

Case study: Pfizer IBD: Employ co-creation and leverage corporate entrepreneurship to identify, action and bring breakthrough to patients lives

  • From blockbuster to breakthrough: Employ digital to maximise personalised patient value
  • Discover how Pfizer is reinventing patient centricity imperatives; in culture, in business way of working and in external communication
  • Case study: How patient co-creation drove innovative digital app development, adding tangible value to patients living with IBD
  • How ensuring high-quality, reliable, and digestible content can build greater patient trust in your organization and drive industry reputational recovery
  • Empower patient to patient connections to build a connected and empowered community: How Janssen with me is overcoming regulatory hurdles to build support networks based on shared patient needs

Serra Karaarslan Patient Initiatives & Digital Commercial Excellence Lead Pfizer

1:45pm – 2:00pm (CET) · Monday, 18th October

Sponsored Thought Leadership Opportunity

  • For more information, reach out to Maddie Sheard, Director of Business Development

2:00pm – 2:15pm (CET) · Monday, 18th October

Case study:Ensure patient connected health objectives across the entire patient journey to drive personalised care pathways

  • Discover how to leverage digital assessments of mobility characteristics in Osteoarthritis and across various indications
  • Employ novel AI and ML innovations to build patient and physician understanding of individualized mobility characteristics and drive personalized support and educational interventions
  • Employ a fully managed end-to-end engagement programme across the patient journey to drive long-term and short-term patient health objectives and empower patient ownership of individual health

Panos Papakonstantinou Global Digital Engagement Leader Roche

2:15pm – 2:30pm (CET) · Monday, 18th October

Live Q&A: Reimagine digital patient engagement to reach diverse patient populations and gain real-world journey understanding

  • Quiz our expert speakers on their case studies and their views on the future

Panos Papakonstantinou Global Digital Engagement Leader Roche

Patient centricity in practice across the value chain

12:30pm – 12:45pm (CET) · Wednesday, 20th October

Beyond centricity: move beyond cultural acceptance to scale action and champion patient voices from R&D to commercial

  • From building and maintaining long-term stakeholder relationships to synced and centered insights across the global – explore the scope of the new patient-centric requirements
  • The impact of rising patient-centric adoption on international healthcare trends; from the emergence of patient advisory efforts in non-traditional markets, to the increasing impact of patient experience data across sponsor, regulatory and market access stakeholder decision-making
  • Empower your teams with the tools they need to deliver the impacts of patient centricity, from faster innovation to wider patient access, and a reduction in cost and time to market

Vicky DiBiaso Global Head, Patient Informed Development & Health Value Translation Sanofi

12:45pm – 1:30pm (CET) · Wednesday, 20th October

Panel:The new benchmarks of great patient engagement

  • How to measure “success” across all touchpoints and platforms across your organisation, from face-to-face to new digital and automated tools, and legitimize your benchmarking results
  • Determine novel outcomes based on real patient need with a flexible disease appropriate approach to platforms, technologies and engagement plan
  • Shift from quantitative to qualitative: Identify, adopt and implement quality-of-life and tangible benefit KPIs in your patient engagement strategy

Shannon Altmari Global Head, Advocacy to Outcomes GSK

Teresa Ferreiro Patient advocate

Jennifer Cain Birkmose VP, Global Head of Patient Access and Community Engagement SOBI

Oleks Gorbenko Global Patient Centricity Director Ipsen

1:30pm – 1:45pm (CET) · Wednesday, 20th October

Case study:Systematize patient engagement with the PARADIGM digital tool

  • Discover how Janssen used PARADIGM, a digital patient engagement insight and analysis tool to systemize patient engagement throughout the company across disease strategies
  • How Janssen built a cross-organisation platform and glossary for patient engagement using PARADIGM to structure the collection, organization and application of patient insights across EU sites.
  • Learn how to assess the success and usefulness of pre-existing core activities, restructure existing strategies and reform community engagement based on insights formed with the PARADIGM methodology.

Daniel de Schryver Patient Engagement & Advocacy Lead, EMEA Janssen

1:45pm – 2:00pm (CET) · Wednesday, 20th October

Sponsored Thought Leadership Opportunity

  • For more information, reach out to Maddie Sheard, Director of Business Development

2:00pm – 2:15pm (CET) · Wednesday, 20th October

Case study:Operationalizing the Embracing Carers™ initiative to unlock new pathways to patient-drive innovation

  • How the pandemic has impacted unpaid carers: New results of the Carer Well-Being Index which surveyed over 9,000 respondents in Europe, Asia, and the Americas to understand economic, physical and mental well-being impacts
  • Understand how caregiver engagement can help provide you with a multitude of valuable new patient insights and unlock pathways to innovative clinical outcomes
  • Explore the practical steps used to operationalize caregiver insights within trial design in the phase III programme for Investigational Evobrutinib in Relapsing Multiple Sclerosis.

Vanessa Pott Director, Global Patient Insights & Advocacy Merck KGaA

2:15pm – 2:30pm (CET) · Wednesday, 20th October

Live Q&A: Patient centricity in practice across the value chain

  • Quiz our expert speakers on their case studies and their views on the future

Vanessa Pott Director, Global Patient Insights & Advocacy Merck KGaA

Daniel de Schryver Patient Engagement & Advocacy Lead, EMEA Janssen

Patient quality of life: Your new access priority

10:00am – 10:15am (CET) · Wednesday, 13th October

Fireside chat:Balance the needs of stakeholders to ensure a more collaborative future and advance patient care

  • Discover how Sanofi assess the value of collaboration and incorporate varied stakeholder perspectives from diagnosis to treatment and long-term patient journeys
  • Understand your role in aligning all stakeholders to enable patients to live life without limits, predicting the future of decision-making to drive sustainable access
  • How to anticipate new global healthcare marketplace trends in an era of unrecognised change to address unmet needs as a community

Vanessa Wolfeler Global Franchise Head, Rare Blood Disorders Sanofi Genzyme

10:15am – 11:00am (CET) · Wednesday, 13th October

Panel:A roadmap for value-based care post-pandemic: It’s now or never to improve patient outcomes

  • One for all or all for one? Ensure a sustainable market for mainstream drugs that can withstand the shift to outcome-based therapies
  • Assess the wider societal and patient implications of the shift towards personalised precision medicine
  • Align contradictory stakeholder objectives to drive the adoption of value-based healthcare out of the pandemic

Martin Price VP, Health Economics, Market Access & Reimbursement, Janssen

Ulf Staginnus Market Access Executive

Sylvie Greneche Head of Global Market Access, General Medicines Sanofi

11:00am – 11:15am (CET) · Wednesday, 13th October

Presentation:Innovative solutions for patient access: the case of telemedicine in hemophilia

  • Understand how Value Based Heath Care can be applied for improving price and access
  • Discover how CSL Behring overcame barriers to patient engagement and facilitated continues access to treatment through ‘easy telemedicine’ a project to redesign the patient journey using existing communication platforms
  • Learn how CSL Behring is build patient confidence in access innovations through collaboration and education

Lara Pippo Head, Market Access & Government Affairs CSL Behring

11:15am – 11:30am (CET) · Wednesday, 13th October

Sponsored Thought Leadership Opportunity

  • For more information, reach out to Maddie Sheard, Director of Business Development

11:30am – 11:45am (CET) · Wednesday, 13th October

Case study:Value, access and reimbursement of gene therapies for rare genetic disorders - Zolgensma case study

  • Understand why gene therapies for rare genetic disorders require healthcare systems to re-envision how they value one-time transformative therapies
  • Discover how to achieve cross-collaboration at a European level and why it’s the key to securing patient access to innovative gene therapies
  • Zolgensma case study: Discover how Novartis Gene Therapies developed bespoke solutions to support rapid access within European healthcare systems

Mike Fraser General Manager, Europe, Middle East & Africa Novartis Gene Therapies

11:45am – 12:00pm (CET) · Wednesday, 13th October

Live Q&A: Patient quality of life: Your new access priority

  • Quiz our expert speakers on their case studies and their views on the future

Lara Pippo Head, Market Access & Government Affairs CSL Behring

Mike Fraser General Manager, Europe, Middle East & Africa Novartis Gene Therapies

Evidence is everything

10:00am – 10:15am (CET) · Friday, 15th October

Fireside chat: Drive data-driven decision-making across the lifecycle with integrated evidence generation

  • Support evidence needs across lifecycle, from development to access and post-launch, with integrated capabilities connecting teams, functions and data sources
  • Educate commercialization strategy with early endpoint identification and holistic insights that breakthrough product silos
  • Instil an evidence-based culture across your organisation with corporate education with real-world value metrics

Sandeep Burugupalli Senior Director, RWE Strategy, Partnerships, and Operations Lead Pfizer

10:15am – 11:00am (CET) · Friday, 15th October

Panel: The roadmap for RWE-harmonization across European healthcare

  • Kickstart a new era of data quality and study capability: Defining the roles of health stakeholders to drive co-creation and mature data infrastructure
  • Target and harmonize investment into data ecosystems, such as registries, to enable more high quality, integrated evidence generation
  • Understand the latest in how health authorities are assessing real-world study quality factors, such as outcome selection, study design and analysis methodology

Enkeleida Nikai-Fitzgerald Senior Director, Head of Real World Evidence, EMEA Janssen

11:00am – 11:15am (CET) · Friday, 15th October

Case Study: Unlock the full value from your RWE through synthetic control arms

  • Learn how to collaborate and leverage SCAs and pave the way for faster access for patients
  • Understand how you can create a foundation for SCA success within your company walls

Sreeram Ramagopalan Global Head, Real-World Evidence Roche

11:15am – 11:30am (CET) · Friday, 15th October

Case Study: How can RWD contribute to maximize the value of your products across the value chain?

Thought leadership from Cegedim

Gilles Paubert Global Head of Cegedim Health Data Cegedim

11:30am – 11:45am (CET) · Friday, 15th October

Discover new trends and insights from your RWD with mature AI and Machine Learning implementation

  • Understand the developing acceptance of AI-driven evidence and analysis from health authorities and other health stakeholders
  • Gain and demonstrate new value from your data with novel trend identification beyond traditional analysis capabilities
  • How NLP is being applied to extract structured data from unstructured sources at scale

Jennie Medin Global Head Real World Science & Digital AstraZeneca

11:45am – 12:00pm (CET) · Friday, 15th October

Live Q&A: Evidence is everything

  • Quiz our expert speakers on their case studies and their views on the future

Jennie Medin Global Head Real World Science & Digital AstraZeneca

Sreeram Ramagopalan Global Head, Real-World Evidence Roche

Gilles Paubert Global Head of Cegedim Health Data Cegedim

Scale new market access models: Pricing, partnership and digital innovation to ensure health equity

12:30pm – 12:45pm (CET) · Thursday, 21st October

Fireside chat:The imperative of equal access to treatment: How Bristol Myers Squibb is working to meet diverse needs across the European access market

  • Understand how differences in market authorization across Europe results in vast disparities for patient access
  • Discover All.Can, an international multi-stakeholder organisation empowering collaboration for improved outcomes in cancer care
  • Learn how BMS is working to make Opdivo available in the West Balkans region

Ester Banque SVP and Head, Intercontinental Bristol Myers Squibb

12:45pm – 1:30pm (CET) · Thursday, 21st October

Panel:The digital disruption of market access

  • Understand how integrated digital healthcare ecosystems are driving the future of payer relationships and collaboration
  • Discover how the digital transformation is reshaping access, from value propositions to healthcare delivery
  • Build the capabilities needed to leverage digital innovation, from data management and AI to evidence generation, digital adaptative dossiers and stakeholder interactions

Raquel Riol Head, Market Access AMESA region Sanofi

Adam Kundewicz Head, Global Strategic Market Access Initiatives Boehringer Ingelheim

Clare Hague Senior Director, Therapy Area Market Access Leader, Hematology Janssen

1:30pm – 1:45pm (CET) · Thursday, 21st October

Fireside chat: Collaboration as the key to accelerating the new market access model

  • Discover why a new approach to market access is needed in a post-pandemic world
  • Turn innovation into value for patients – how Astellas is bridging the gap
  • Why aligning stakeholders around the value of patient insights is key

Jackie Williams General Manager, UK Astellas

1:45pm – 2:00pm (CET) · Thursday, 21st October

Sponsored Thought Leadership Opportunity

  • For more information, reach out to Maddie Sheard, Director of Business Development

2:00pm – 2:15pm (CET) · Thursday, 21st October

Case study:Entresto. How a patient-centric global mindset drove regulatory innovation and accelerated approval and reimbursement

  • Discover how Novartis Albania utilised FDA approvals to become the second country in Europe to register Entresto, fast-tracking beyond the EMA
  • Understand how to use patient engagement and public health campaigns to accelerate reimbursement
  • Learn how the multilateral success of Entresto has shaped the culture of access in Novartis Albania, driving the adoption of greater multifunctional collaboration and shaping patient engagement strategies

Melissa Troshani Head, Patient Access Public Affairs Novartis

2:15pm – 2:30pm (CET) · Thursday, 21st October

Live Q&A: Scale new market access models: Pricing, partnership and digital innovation to ensure health equity

  • Quiz our expert speakers on their case studies and their views on the future

Jackie Williams General Manager, UK Astellas

Melissa Troshani Head, Patient Access Public Affairs Novartis

Opening Keynote Themes and Speakers

Overview:The future of European Healthcare

  • Shape the European healthcare system of the future through collaboration to align stakeholders around patient value and ensure access for future pharma innovation
  • European Pharmaceutical Strategy, a review: the first step to a more sustainable health future? See the impact of key legislation on your pipelines and future products
  • Democratise healthcare through a digital revolution, fuelled by the growing power of patient-owned health data
  • Prime your future strategies for the advent of smaller, more targeted patient population groups through the blueprint of rare disease engagement strategies

Nathalie Moll Director General EFPIA

Richard Daniell EVP, Head of Europe Commercial Teva

Giles Platford President, Europe & Canada Takeda

Iskra Reic EVP, Europe & Canada AstraZeneca

Stefan Oelrich President, Pharmaceuticals Bayer

Opening Keynote Themes and Speakers

Overview:Reimagine pharma to unleash it's potential

  • Viva la commercial revolution: Why it’s now or never to redefine the nature of the pharma customer experience – or fall behind your customer’s rapidly changing needs
  • The technology of tomorrow, today: How the cocktail of AI, predictive analytics and increasing data maturity is transforming decision-making across the value chain and removing entry barriers to new therapeutic areas
  • Surpass centricity: Pioneer patient-led innovation to ensure the greatest unmet need is fulfilled with your next blockbuster
  • Scale, scale, scale! Go beyond CoEs and lighthouse projects – embed innovations across functions, regions and stakeholders

Marie-France Tschudin President, Pharmaceuticals Novartis

Catherine Mazzacco President & CEO LEO Pharma

Myrtle Potter CEO Sumitovant Biopharma

Carinne Brouillon Head, Human Pharma, Board of Managing Directors Boehringer Ingelheim

Bill Sibold EVP & Head Sanofi Genzyme

Commercial Excellence through digital transformation

10:00am – 10:15am (CET) · Tuesday, 12th October

Fireside chat:Your burning platform! Create digital - and people - transformation during commercial pharma’s industrial revolution

  • Don’t get left behind. It’s now or never to increase digital capabilities, disrupt the market, and deliver true customer centricity
  • How to clearly outline new business priorities and get buy-in from those who will be affected the most to enable accelerated transformation
  • Digital isn't a channel, it's a way of doing business. Key principles for a digitally enabled commercial model that delivers improved experiences for HCPs, payers, patients, and peers

Nikos Georgiades former SVP, Global Head of Digital Commercial Execution Novartis

10:15am – 11:00am (CET) · Tuesday, 12th October

Panel:Stop cleanin’ windows and change the foundation. ‘Cause right now you’re doing digitization not digital transformation

  • Ensure a complete customer experience by reimaging the core customer engagement model - break silos and mold cross-functional teams to deliver personalised value
  • Overcome market archetype differences to get global and local on the same page to enable savings, efficiencies, and effectiveness
  • It’s not just innovation for innovation’s sake. Understand how to identify new capabilities that hit on your business strategy and deliver for customers and patients alike

Erasmus Holm Chief Marketing Officer, Nordics MSD

Renee Amundsen Global Head, Business Innovation Merck Group

Elliot Antrobus-Holder Global Head, Omnichannel Gilead

Sierra Towers Global Head, Omnichannel Excellence Boehringer Ingelheim

Hanno Ronte Life Science and Healthcare Partner Deloitte

11:00am – 11:15am (CET) · Tuesday, 12th October

Case study:Transform your customer engagement capabilities through more educated rep engagement and effective change management

  • Communicate the strategic vision of the company so the field force commits to new ways of working and you don’t lose them along the journey
  • Empower your reps! Maximize on rep insights to co-create strategy, solve specific customer pain points, and deliver on sales goals
  • Apply new tech to field operations to enable smoother planning to execution processes that are tailored for your customer needs
  • How to use an online educational content hub to trigger rep-driven conversations with HCPs for a connected customer journey

Laia Gil Molas Commercial Operations Manager, Iberia Alexion

11:15am – 11:30am (CET) · Tuesday, 12th October

Engaging health care practitioners with purpose and impact

  • Explore why relying on high volumes of sales touchpoints doesn’t equate to patients with unmet needs receiving the right treatment, even if it yields a “positive ROI curve”
  • Ensure innovative treatments reach the patients who need them, by deploying a wider range of engagement types across the provider journey – including medical education, early diagnosis assistance, access support, patient support tools and traditional sales and marketing
  • Unlock purpose-driven engagement by taking a holistic view of each individual HCP, combining data-driven and field-based insights to select the right balance for everyone
  • Leverage technology, best practices in advanced analytics and flexible ways of working to allocate and deploy resources and capabilities dynamically every 3 – 6 months

Brent Hooper Partner, Global Leader of HCP Engagement McKinsey & Co

11:30am – 11:45am (CET) · Tuesday, 12th October

Case study:Shape your digital innovation model and capitalize on new commercial opportunities

  • Digital transformation, an enabler towards business innovation. Who needs to drive the change
  • The key success factors for customer centricity, and applying precision analytics in the commercial world
  • Lessons learnt on shaping a digital innovation commercial strategy to capture new opportunities

Mostafa Taha Chief Transformation Lead, Global Merck Group

11:45am – 12:00pm (CET) · Tuesday, 12th October

Live Q&A: Commercial Excellence through digital transformation

  • Quiz our expert speakers on their case studies and their views on the future

Laia Gil Molas Commercial Operations Manager, Iberia Alexion

Mostafa Taha Chief Transformation Lead, Global Merck Group

The new engagement model for Medical Affairs

12:30pm – 12:45pm (CET) · Tuesday, 12th October

Fireside chat:Achieve best-in-class Medical Affairs engagement for the future

  • Deliver a personalised stakeholder experience through a multichannel strategy that balances physical and virtual interactions
  • Reimagine performance metrics across all HCP interactions to foster a physician-centric cultural transformation across your entire company and continuously recalibrate engagement models to meet evolving customer needs
  • Witness the future of Medical Affairs-led product launches that deliver a more valued HCP experience and market changing impact

Steven Hildemann EVP, Chief Medical Officer, Head of Global Medical Affairs, Patient Safety and Patient Affairs Ipsen

12:45pm – 1:30pm (CET) · Tuesday, 12th October

Panel:Medical Omnichannel Transformation: Why personalization and a digitally-enabled omni-channel strategy matters for Medical Affairs and how you can accelerate your transformation

  • Cure your physician’s virtual hangover by creating a sepmless multi-channel journey that aligns to personal preference and adds value to their daily patient interactions
  • Stand out in the crowded-digital environment by using social listening to deliver actionable insights from every interaction to inform your engagement approach
  • Optimise your physician experience through data-driven insights that personalise your dynpmic content and channel strategy

Kumaran Krishnan Director, Medical Excellence & Medical Information AstraZeneca

Robert Stevens VP, Global Head Digital Medical Affairs Novartis

Pierre Côte Transversal Project Lead, Franchise & Product Strategy Sanofi Pasteur

Moderator: Annaë Liu Medical Head, Cell & Gene, Oncology Novartis

1:30pm – 1:45pm (CET) · Tuesday, 12th October

Case study:“Hey Google, talk to Bayer Pharmaceutical.” How Bayer has enhanced HCPs access to medical information through Virtual Voice Assistant (pmI)

  • Learn how Bayer’s Medical Affairs tepm drove a cross-functional approach to pioneer innovative technology adoption inspired by analysis of physician need
  • Discover how to enhance your physician’s experience by providing faster access to relevant information through voice technology
  • See the blueprint for introducing voice technology to your company

Wagdy Youssef Senior Director US Medical Communication, Medical Information, Publication & Digital Transformation Bayer

1:45 – 2:00pm (CET) · Tuesday, 12th October

Thought leadership from Within3

2:00pm – 2:15pm (CET) · Tuesday, 12th October

Case study:Expand your reach by embracing the new-generation of scientific – how to identify and work with Digital Opinion Leaders #Trending #DOLs #MedicalAffairs

  • Learn how to identify the right DOLs to chpmpion your content and enhance your reputation across new physician demographics
  • Capture a wide range of insights from your DOLs engagement activity that can refine strategy across all channels, not just social

2:15pm – 2:30pm (CET) · Tuesday, 12th October

Live Q&A: The new engagement model for Medical Affairs

  • Quiz our expert speakers on their case studies and their views on the future

Wagdy Youssef Senior Director US Medical Communication, Medical Information, Publication & Digital Transformation Bayer

Patient quality of life: Your new access priority

10:00am – 10:15am (CET) · Wednesday, 13th October

Fireside chat:Balance the needs of stakeholders to ensure a more collaborative future and advance patient care

  • Discover how Sanofi assess the value of collaboration and incorporate varied stakeholder perspectives from diagnosis to treatment and long-term patient journeys
  • Understand your role in aligning all stakeholders to enable patients to live life without limits, predicting the future of decision-making to drive sustainable access
  • How to anticipate new global healthcare marketplace trends in an era of unrecognised change to address unmet needs as a community

Vanessa Wolfeler Global Franchise Head, Rare Blood Disorders Sanofi Genzyme

10:15am – 11:00am (CET) · Wednesday, 13th October

Panel:A roadmap for value-based care post-pandemic: It’s now or never to improve patient outcomes

  • One for all or all for one? Ensure a sustainable market for mainstream drugs that can withstand the shift to outcome-based therapies
  • Assess the wider societal and patient implications of the shift towards personalised precision medicine
  • Align contradictory stakeholder objectives to drive the adoption of value-based healthcare out of the pandemic

Martin Price VP, Health Economics, Market Access & Reimbursement, Janssen

Ulf Staginnus Market Access Executive

Sylvie Greneche Head of Global Market Access, General Medicines Sanofi

11:00am – 11:15am (CET) · Wednesday, 13th October

Presentation:Innovative solutions for patient access: the case of telemedicine in hemophilia

  • Understand how Value Based Heath Care can be applied for improving price and access
  • Discover how CSL Behring overcame barriers to patient engagement and facilitated continues access to treatment through ‘easy telemedicine’ a project to redesign the patient journey using existing communication platforms
  • Learn how CSL Behring is build patient confidence in access innovations through collaboration and education

Lara Pippo Head, Market Access & Government Affairs CSL Behring

11:15am – 11:30am (CET) · Wednesday, 13th October

Sponsored Thought Leadership Opportunity

  • For more information, reach out to Maddie Sheard, Director of Business Development

11:30am – 11:45am (CET) · Wednesday, 13th October

Case study:Value, access and reimbursement of gene therapies for rare genetic disorders - Zolgensma case study

  • Understand why gene therapies for rare genetic disorders require healthcare systems to re-envision how they value one-time transformative therapies
  • Discover how to achieve cross-collaboration at a European level and why it’s the key to securing patient access to innovative gene therapies
  • Zolgensma case study: Discover how Novartis Gene Therapies developed bespoke solutions to support rapid access within European healthcare systems

Mike Fraser General Manager, Europe, Middle East & Africa Novartis Gene Therapies

11:45am – 12:00pm (CET) · Wednesday, 13th October

Live Q&A: Patient quality of life: Your new access priority

  • Quiz our expert speakers on their case studies and their views on the future

Lara Pippo Head, Market Access & Government Affairs CSL Behring

Mike Fraser General Manager, Europe, Middle East & Africa Novartis Gene Therapies

Digital health innovation as your competitive advantage

12:30pm – 12:45pm (CET) · Wednesday, 13th October

Fireside chat:Transformative digital technologies start with an alignment of business objectives and outcomes

  • How Almirall used the expertise of its Digital Garden entrepreneurs to create their own intrapreneurs to boost the efficiency and effectiveness of digital operations
  • Solving for the commercial imperative. Partner with start-ups as they still develop their business models, whilst also collaborating with established companies who can deliver on strategy right away

Francesca Wuttke Chief Digital Officer Almirall

12:45pm – 1:30pm (CET) · Wednesday, 13th October

Panel:From ideation to commercial success. Crack the digital innovation model

  • Explore what a solution could be by rapidly building and testing iterations. What capabilities are needed for your lighthouse projects
  • Different commercial models for your digital projects to ensure innovation doesn’t perish. How to choose between spinning the project out, creating a new BU, adding as a companion and everything in between for your project
  • Translators and Navigators. Finding internal champions and working with partners that can deliver on your vision

Chris Easton Senior Director, Global Commercial Lead, Personalized Health & Innovation, Rare Hematology Takeda

Catalina Cernica CEO Health & Happiness Foundation

Emma Hoglund Head Commercial Excellence & Digital Strategy Novartis

1:30pm – 1:45pm (CET) · Wednesday, 13th October

Case study:UCB: Develop a mature digital innovation strategy to fundamentally change care pathways for people living with severe chronic diseases

  • Case Study: How UCB is enabling earlier detection and diagnosis of patients through digital platforms and by collaborating with likeminded partners
  • Empowering your teams to capatilise on current and future patient needs through digital mindsets and culture, data, strategy and capabilities

Erik Janssen VP, Digital Transformation UCB

1:45pm – 2:00pm (CET) · Wednesday, 13th October

IQVIA Thought Leadership

Romain Lasry Senior Director, Commercial Analytics and AI/ML Innovation IQVIA

2:00pm – 2:15pm (CET) · Wednesday, 13th October

Case study:Digital health innovation through new types of transformation and partnerships

  • An assessment of fit-for-purpose technology that enables quick adoption without losing flexibility
  • How a collaborative business model enables you to fast-track development and improve digital innovation

2:15pm – 2:30pm (CET) · Wednesday, 13th October

Live Q&A: Digital innovation as your competitive advantage

  • Quiz our expert speakers on their case studies and their views on the future

Erik Janssen VP, Digital Transformation UCB

Romain Lasry Senior Director, Commercial Analytics and AI/ML Innovation IQVIA

Data centricity: for more intelligent decision-making and efficient commercial operations

10:00am – 10:15am (CET) · Thursday, 14th October

Fireside chat:The guidebook to creating a data-driven commercial organization

  • Get your entire organisation bought into the value of becoming data-driven by finding your change-makers to drive the project forward
  • Key principles to finding the technology and analytics partners that will serve your needs and create exceptional business outcomes
  • Data is alive. Understand why this isn’t a project, but a product evolution that is never finished

10:15am – 11:00am (CET) · Thursday, 14th October

Panel:Build your analytics muscle to understand customer behaviour and solve unseen pain points

  • How to successfully deploy AI, ML and advanced analytics: avoid over-complexity and inefficiency by ensuring your data management process and infrastructure are in order to enable quick adoption of new technologies
  • Educate to elevate. Ensure your data and digital literacy is of the highest caliber with a mindful approach to change management
  • Data governance: Discuss different buy or own models to find which approach will be the best fit for your purpose

Sital Kotecha Commercial Excellence Director, Growth Markets Sobi

Neelesh Shanbhag CIO & VP, Business Technology, Asia Pacific Janssen

Megan Hughes Global Head, Omnichannel Analytics Grunenthal

Morten Kruse-Jacobsen Senior Global Director, Multichannel Excellence & Operations Novo Nordisk

11:00am – 11:15am (CET) · Thursday, 14th October

Case study:Maximize the digital marketing experience with a test and learn mindset

  • Define marketing objectives and successfully roadmap your strategy
  • Install a hypothesis-based approach to all your marketing projects
  • Iterate, scale or abandon: How to successfully leverage data-driven Insights

Brett Marvel Associate Director, Digital Engagement MSD

11:15am – 11:30am (CET) · Thursday, 14th October

Sponsored Thought Leadership Opportunity

  • For more information, reach out to Maddie Sheard, Director of Business Development

11:30am – 11:45am (CET) · Thursday, 14th October

Case study:AI coming to the rescue: new technologies that enhance your business and customer intelligence capabilities

  • Create your data-organization, link multiple data sources - whether structured or unstructured - and build your predictive model to create customer behaviour profiles that can characterize new engagement opportunities
  • Scanning, characterizing available technologies and applying agile, design thinking processes to create a robust, end-to-end pilot to scale

Daniel Vertessy Business Development & Customer Intelligence Manager, DACH Region Aspen

11:45am – 12:00pm (CET) · Thursday, 14th October

Live Q&A: Data centricity: for more intelligent decision-making and efficient commercial operations

  • Quiz our expert speakers on their case studies and their views on the future

Brett Marvel Associate Director, Digital Engagement MSD

Daniel Vertessy Business Development & Customer Intelligence Manager, DACH Region Aspen

Reimagine your Medical Affairs capabilities

12:30pm – 12:45pm (CET) · Thursday, 14th October

Fireside chat:Pharma’s third pillar: Medical Affairs. Deliver value across the organisation from your seat in the boardroom

  • Embody the voice of patients and physicians within your organisation to ensure stakeholder centricy is ever-present
  • See how a separate and independent Medical Affairs function can prosper to deliver added value to the business

Harmony Garges Chief Medical Officer ViiV Healthcare

12:45pm – 1:30pm (CET) · Thursday, 14th October

Panel:Modernise Medical Affairs: The new skills, roles and capabilities needed for engagement success in the new healthcare environment

  • Create a team capable of delivering a mature multi-channel strategy by upskilling the digital competencies and soft skills of your Medical Affairs workforce
  • Achieve new levels of external value by forging new roles and responsibilities the reflect the changing image of physician need
  • Create global-to-local structures that provide support and flexibility to empower and inspire local teams to personalise their HCP engagement strategies

Christian Velten Global Head, Medical Customer Experience Roche

Joshua Corriveau Senior Director, Global Field Medical Excellence LEO Pharma

Monica de Abadal VP, Medical Excellence, Global Medical Affairs Ipsen

Moderator: Domenico Curinga Medical Head, Haematology Novartis

1:30pm – 1:45pm (CET) · Thursday, 14th October

Case study:How AstraZeneca International reimagined their Medical roles and responsibilities around changing HCP and patient needs

  • Recruit data-savvy Medical Affairs operatives to optimise your data collection and insight generation processes
  • Understand why AstraZeneca created new roles for Medical Educators and Clinical Science Liaisons to shape the primary care ecosystem and ensure the best patient experience / outcomes

Alex Bedenkov VP, Medical International & Global Health Innovation Hubs Network Head AstraZeneca

1:45pm – 2:00pm (CET) · Thursday, 14th October

Thought leadership from HCG

2:00pm – 2:15pm (CET) · Thursday, 14th October

Case study:And in the beginning… How to create a decentralised Medical Affairs organisation from scratch

  • Learn how a decentralised approach to building a Medical Affairs organisation during the pandemic has enabled faster expansion of influence across Europe
  • Integrate evidence generation into the fabric of your Medical Affairs function across clinical and commercial to deliver an agile content creation strategy

2:15pm – 2:30pm (CET) · Thursday, 14th October

Live Q&A: Reimagine your Medical Affairs capabilities

  • Quiz our expert speakers on their case studies and their views on the future

Alex Bedenkov VP, Medical International & Global Health Innovation Hubs Network Head AstraZeneca

Assemble your new data and digital salesforce

10:00am – 10:15am (CET) · Monday, 18th October

Fireside chat:Hybrid engagement is here to stay – but how do you decide to what degree?

  • Develop a holistic view of your customer-facing teams for more systematic and tailored operations management
  • Less time spent travelling is your field team’s opportunity to chase more value-add opportunities
  • How to vanquish the hybrid model rep fear factor and develop your change management initiative

Ivan Blanarik Corporate SVP, Head of CardioMetabolic & Respiratory Boehringer Ingelheim

10:15am – 11:00am (CET) · Monday, 18th October

Panel:Increase your SFE with performance management approaches and capability building fit for hybrid engagement

  • Bridge the gap between your virtual and F2F capabilities through a thorough understanding of each environment’s strengths (and weaknesses)
  • More than call rates: How to change your incentives structure to reflect the shift to hybrid, customer relationship building and interactions
  • Soft selling in the virtual environment is the key to relationship building and devising common value for future success

Alexey Cherchago Head of Sales Excellence, Europe Sandoz

Chris Mann Head of Commercial Excellence, UK & Ireland Amgen

Philip McCrea Managing Director Europe Red Nucleus

11:00am – 11:15am (CET) · Monday, 18th October

Break

11:15am – 12:00pm (CET) · Monday, 18th October

Panel: Embrace technology efficiencies to increase your sales effectiveness

  • How to increase sales outputs by strengthening your business processes when implementing new technologies or rolling out to new affiliates
  • Technology disruption that aligns with your people transformation: Equip reps with digital and data expertise and see them flourish in the tech-centric environment
  • Correct use of your CRM to unlock the true-value of your customer engagement strategy

Massimiliano Siciliano Digital Solution Director Novartis

Rorik van Welij Worldwide Omni-channel Capability Lead Bristol Myers Squibb

Baptiste Mercier SVP, Commercial & Digital Marketing Services & Products BASE life science

Reimagine digital patient engagement to reach diverse patient populations and gain real-world journey understanding

12:30pm – 12:45pm (CET) · Monday, 18th October

Fireside chat:Patient engagement and pharma’s digital responsibility

  • Define pharma’s societal responsibility to set and achieve ethical standards for digital leadership
  • Understand the role of digital innovation and leadership to safeguard against data biases and ensure greater diversity and equity in patient engagement and outcomes. Understand the role of digital innovation to drive pharma towards a more diverse and equitable future
  • Deliver meaningful value to the patients, caregivers and society through economically, socially and environmentally sustainable progress towards patient-centric digital engagement

Nick Passey Commercial Digital and IT Vice President AstraZeneca

12:45pm – 1:30pm (CET) · Monday, 18th October

Panel:Employ innovations in digital engagement to empower a new generation of patient advocates

  • Explore the changing relationship between patients and HCPs and how you can fill the widening education and support gap
  • Employ innovative tools and platforms to build a multichannel engagement and educational strategy that will facilitate patient engagement across a more diverse patient audience
  • Engage a younger generation of advocates to reach new patient populations and gain more varied insights: The world of social media and health influencers
  • Give back with digital: Discover how we can repurpose our digital engagement expertise to support advocates and organizations.

Christina Kotsi Patient Engagement & Insights Project Manager Novartis

Geoff Rollason Director, Patient Experience & Service, Oncology, UK Pfizer

Mark Sterckel Senior Patient Engagement Director Ferring Pharmaceuticals

Stephanie Bach Director, UX ZS Medullan

1:30pm – 1:45pm (CET) · Monday, 18th October

Case study: Pfizer IBD: Employ co-creation and leverage corporate entrepreneurship to identify, action and bring breakthrough to patients lives

  • From blockbuster to breakthrough: Employ digital to maximise personalised patient value
  • Discover how Pfizer is reinventing patient centricity imperatives; in culture, in business way of working and in external communication
  • Case study: How patient co-creation drove innovative digital app development, adding tangible value to patients living with IBD
  • How ensuring high-quality, reliable, and digestible content can build greater patient trust in your organization and drive industry reputational recovery
  • Empower patient to patient connections to build a connected and empowered community: How Janssen with me is overcoming regulatory hurdles to build support networks based on shared patient needs

Serra Karaarslan Patient Initiatives & Digital Commercial Excellence Lead Pfizer

1:45pm – 2:00pm (CET) · Monday, 18th October

Sponsored Thought Leadership Opportunity

  • For more information, reach out to Maddie Sheard, Director of Business Development

2:00pm – 2:15pm (CET) · Monday, 18th October

Case study:Ensure patient connected health objectives across the entire patient journey to drive personalised care pathways

  • Discover how to leverage digital assessments of mobility characteristics in Osteoarthritis and across various indications
  • Employ novel AI and ML innovations to build patient and physician understanding of individualized mobility characteristics and drive personalized support and educational interventions
  • Employ a fully managed end-to-end engagement programme across the patient journey to drive long-term and short-term patient health objectives and empower patient ownership of individual health

Panos Papakonstantinou Global Digital Engagement Leader Roche

2:15pm – 2:30pm (CET) · Monday, 18th October

Live Q&A: Reimagine digital patient engagement to reach diverse patient populations and gain real-world journey understanding

  • Quiz our expert speakers on their case studies and their views on the future

Panos Papakonstantinou Global Digital Engagement Leader Roche

Go-to-Market Mastery

12:30pm – 12:45pm (CET) · Tuesday, 19th October

Fireside chat:The GTM Model Evolved: A practical assessment from different markets to improve your customer engagement

  • Digital isn’t the be all and end all in a virtual world – harness omni channel to unleash new GTM models
  • Field interactions still hold the trump card to understanding customers and delivering results – an assessment on how this will evolve in the mid-term
  • Changing the way we communicate to customers requires mindset shifts for our market teams – how to bring them with us on the journey

Catherine Owen SVP, Major Markets Bristol Myers Squibb

12:45pm – 1:30pm (CET) · Tuesday, 19th October

Panel:A data and digital enabled GTM strategy for long-term business impact

  • Equal voices at the strategy meeting: Why an aligned and cross-functional GTM strategy has never been more important – and how to balance strategic priorities
  • Working backwards. Define your channel and content mix based on customer behaviours and create experiences that HCPs crave
  • The new model tenet: How to build your remote capability through technology enablement and validate your hybrid selling model to ensure reps can hit their newly defined KPIs

Patrick Markt-Niederreiter Head, Digital Excellence, Europe Daiichi Sankyo

Chetak Buaria Global Head, Customer Engagement & Channel Evolution Merck Group

Rohit Sood EVP, EVERSANA™ COMPLETE Commercialization EVERSANA

1:30pm – 1:45pm (CET) · Tuesday, 19th October

Case study:The battle of digital and virtual fatigue: Make your HCP engagement meaningful

  • Get out of the reach and frequency fight. Enhance your customer experience by putting new forms of content and value-add interactions at the heart of your HCP engagement strategy
  • Make data actionable. How to spot technological deficiencies and create a cross-company infrastructure that enables a personalised approach
  • Create a holistic customer experience through a field force strategy that balances both digital and F2F interactions, and product and disease content

Lukas Falk Director, Global Enablement and Capabilities Ipsen

1:45pm – 2:00pm (CET) · Tuesday, 19th October

Sponsored Thought Leadership Opportunity

  • For more information, reach out to Henry Payne, Director of Business Development

2:00pm – 2:15pm (CET) · Tuesday, 19th October

The evolution of the virtual go-to-market model for innovative medicines

Zhen Su Former SVP, Head of Global Oncology Business Franchise EMD Serono

2:15pm – 2:30pm (CET) · Tuesday, 19th October

Live Q&A: Go-to-Market Mastery

  • Quiz our expert speakers on their case studies and their views on the future

Lukas Falk Director, Global Enablement and Capabilities Ipsen

The new face of Field Medical

10:00am – 10:15am (CET) · Tuesday, 19th October

Fireside chat:MSLs Assemble! Pharma’s new leaders for field engagement strategy in post-pandemic healthcare

  • See how your MSL team can be driving force of external engagements going forwards by demonstrating improved value by building physician trust through with higher quality content and interactions
  • Expand the influence of your field medical teams to lead physician-centric cross-functional strategy with KAMs and commercial reps

Christoph Koenen EVP, Chief Medical Officer Otsuka

10:15am – 11:00am (CET) · Tuesday, 19th October

Panel:Equip your field medical teams to flourish through the hybrid transformation

  • Find the balance of physical and virtual interactions to prevent physician fatigue and provide personalised experiences that truly deliver an MSL-led omnichannel experience
  • The digital MSL: Embed digital as a core competency of your field medical team to deliver the now essential physician-centric strategy
  • Enable your field medical team to communicate your scientific storytelling fluidly across different channels to personalise and optimise their engagements

Maja Beilmann-Schramm Director, Global Field Medical Excellence & HCP Exchange Merck Group

Mark Rees-Saunders Director, External Engagement Centre of Excellence, Established Markets Astellas

Sarah Clark Global Head, Medical Affairs and Operations, Digital Health Biogen

11:00am – 11:15am (CET) · Tuesday, 19th October

Fireside chat:Omnichannel orchestrator. The new requirement for your MSLs.

  • Empower your MSLs with data-derived insights that inform a personalised engagement strategy
  • Situate your MSL teams as the bridge between internal and external stakeholder management to deliver insights across the business

Victoria Ho Head, Medical Capabilities and Excellence, EU/ RoW Jazz

11:15am – 11:30am (CET) · Tuesday, 19th October

Empower your MSLs with the power of data

  • See how the full picture of integrated data is a game changer for your MSL team to execute strategies faster and more effectively
  • Manage your key thought leader relationships with user-level custom insights and personalize your engagements

Elke Ydens Solutions Specialist Anju Software

11:30am – 11:45am (CET) · Tuesday, 19th October

Case study:Metrics managed! How multi-channel can finally solve your performance metrics headache

  • Learn how your multi-channel engagement strategy allows you to qualitatively assess virtual engagements and refine future strategy
  • Benchmark MSL engagements across therapy and regions to spot and scale excellence

Heather Moses Country Medical Director, Oncology, UK Novartis

11:45am – 12:00pm (CET) · Tuesday, 19th October

Live Q&A: The new face of Field Medical

  • Quiz our expert speakers on their case studies and their views on the future

Heather Moses Country Medical Director, Oncology, UK Novartis

Victoria Ho Head, Medical Capabilities and Excellence, EU/ RoW Jazz

Elke Ydens Solutions Specialist Anju Software

Establish omnichannel frameworks. Deliver a connected customer experience

10:00am – 10:15am (CET) · Wednesday, 20th October

Fireside chat:Make the move to omnichannel for a rounded customer experience and connected journey

  • Develop your roadmap to enable your omnichannel engagement strategy
  • How to ensure your messaging, content and channels are in-sync and tailored for a customer-centric strategy

Mircea Cubillos Commercial VP, Haematology, EMEA Janssen

10:15am – 11:00am (CET) · Wednesday, 20th October

Panel:Capitalize on your customer engagement strategy through omnichannel

  • Set up frameworks and processes that allow you to roll out your omnichannel strategy for new products and markets
  • Be clear on each person’s role within the strategy – from marketing to the rep orchestrator
  • Use data and insights to understand customer preferences to create experiences that address needs and drive engagement
  • How to ensure your brand strategies are aligned with the customers omnichannel journey

Denis Vallese Global Omnichannel Strategy Lead AstraZeneca

Hans Gilhuys Senior Director, Commercial Digital Gilead

Adela Schulz iEU DBT Strategy & Capabilities Lead, EU Strategy and Operations UCB

Prashant Parab SVP & GM Analytics Solutions IQVIA

11:00am – 11:15am (CET) · Wednesday, 20th October

Case study:Add value at every customer touchpoint with fully contextualized decision-making

  • Take a holistic view across your customer’s whole journey to remove disjointed communications and ensure high quality engagements
  • Finetune your internal tech stack with a CRM system optimized to meet customers needs
  • Effectively implement omnichannel strategy with new cross-functional collaboration frameworks that unlock all available insights and ensure channel interoperability

Andy Kennemer VP, Customer Experience and Digital Innovation GSK

11:15am – 11:30am (CET) · Wednesday, 20th October

TrendMD Thought Leadership

11:30am – 11:45am (CET) · Wednesday, 20th October

Case study:Enabling & empowering rep orchestration in a hybrid set-up

  • From multichannel to omnichannel management for a more strategic and data-driven approach of reps to fulfill customer needs while enhancing patient quality of care
  • Digital technologies to empower and enable reps to reach the right customer with the right channel via the right content and achieve clear-cut business goals
  • Elevation of internal omnichannel capabilities as key to increase reps´ digital maturity and ability of effectively orchestrating channels to increase customer reach and frequency, improve their experience and satisfaction

Yasemin Mehmet Senior Director, Global Customer Engagement Strategy Merck Group

Juliana Guimarães Digital Manager Merck Group

11:45am – 12:00pm (CET) · Wednesday, 20th October

Live Q&A: Establish omnichannel frameworks. Deliver a connected customer experience

  • Quiz our expert speakers on their case studies and their views on the future

Yasemin Mehmet Senior Director, Global Customer Engagement Strategy Merck Group

Juliana Guimarães Digital Manager Merck Group

Patient centricity in practice across the value chain

12:30pm – 12:45pm (CET) · Wednesday, 20th October

Beyond centricity: move beyond cultural acceptance to scale action and champion patient voices from R&D to commercial

  • From building and maintaining long-term stakeholder relationships to synced and centered insights across the global – explore the scope of the new patient-centric requirements
  • The impact of rising patient-centric adoption on international healthcare trends; from the emergence of patient advisory efforts in non-traditional markets, to the increasing impact of patient experience data across sponsor, regulatory and market access stakeholder decision-making
  • Empower your teams with the tools they need to deliver the impacts of patient centricity, from faster innovation to wider patient access, and a reduction in cost and time to market

Vicky DiBiaso Global Head, Patient Informed Development & Health Value Translation Sanofi

12:45pm – 1:30pm (CET) · Wednesday, 20th October

Panel:The new benchmarks of great patient engagement

  • How to measure “success” across all touchpoints and platforms across your organisation, from face-to-face to new digital and automated tools, and legitimize your benchmarking results
  • Determine novel outcomes based on real patient need with a flexible disease appropriate approach to platforms, technologies and engagement plan
  • Shift from quantitative to qualitative: Identify, adopt and implement quality-of-life and tangible benefit KPIs in your patient engagement strategy

Shannon Altmari Global Head, Advocacy to Outcomes GSK

Teresa Ferreiro Patient advocate

Jennifer Cain Birkmose VP, Global Head of Patient Access and Community Engagement SOBI

Oleks Gorbenko Global Patient Centricity Director Ipsen

1:30pm – 1:45pm (CET) · Wednesday, 20th October

Case study:Systematize patient engagement with the PARADIGM digital tool

  • Discover how Janssen used PARADIGM, a digital patient engagement insight and analysis tool to systemize patient engagement throughout the company across disease strategies
  • How Janssen built a cross-organisation platform and glossary for patient engagement using PARADIGM to structure the collection, organization and application of patient insights across EU sites.
  • Learn how to assess the success and usefulness of pre-existing core activities, restructure existing strategies and reform community engagement based on insights formed with the PARADIGM methodology.

Daniel de Schryver Patient Engagement & Advocacy Lead, EMEA Janssen

1:45pm – 2:00pm (CET) · Wednesday, 20th October

Sponsored Thought Leadership Opportunity

  • For more information, reach out to Maddie Sheard, Director of Business Development

2:00pm – 2:15pm (CET) · Wednesday, 20th October

Case study:Operationalizing the Embracing Carers™ initiative to unlock new pathways to patient-drive innovation

  • How the pandemic has impacted unpaid carers: New results of the Carer Well-Being Index which surveyed over 9,000 respondents in Europe, Asia, and the Americas to understand economic, physical and mental well-being impacts
  • Understand how caregiver engagement can help provide you with a multitude of valuable new patient insights and unlock pathways to innovative clinical outcomes
  • Explore the practical steps used to operationalize caregiver insights within trial design in the phase III programme for Investigational Evobrutinib in Relapsing Multiple Sclerosis.

Vanessa Pott Director, Global Patient Insights & Advocacy Merck KGaA

2:15pm – 2:30pm (CET) · Wednesday, 20th October

Live Q&A: Patient centricity in practice across the value chain

  • Quiz our expert speakers on their case studies and their views on the future

Vanessa Pott Director, Global Patient Insights & Advocacy Merck KGaA

Daniel de Schryver Patient Engagement & Advocacy Lead, EMEA Janssen

Create value+ and personalised content for HCP engagement

10:00am – 10:15am (CET) · Thursday, 21st October

Fireside chat:From Push-to-Pull: How to change your content creation approach to meet new customer needs

  • Relying on push marketing is to ignore what customers want. Rebalance your promotional and non-promotional content and usher in a new generation of pharma content
  • Abandon the one-size-fits-all ship. How to identify gaps in creating personalized content and align your capabilities to customer needs

Oscar Perez Chief Marketing, Market Access & Business Development Officer Ferrer

10:15am – 11:00am (CET) · Thursday, 21st October

Panel:Execute a fit-for-multiple-environments content strategy with agile, iterative and customer tailored processes

  • Orientate your content to value by understanding customer needs and then connect the dots for a holistic customer experience
  • How to create content which is unbranded or beyond disease that can create behavior change
  • Chasing consumer brands. Is the customer experience pursuit of Amazon and Apple harming pharma’s ability to deliver on customer-centricity
  • Hear what types of content are having the greatest effect on customers right now

Vanitha S V Global Lead, Modular Content, Multichannel Excellence & Operations Novo Nordisk

Karina Morley Global Head, External Scientific Affairs AstraZeneca

Chetak Buaria Global Head, Customer Engagement & Channel Evolution Merck Group

Tim Russell Executive Vice President M3 (EU)

11:00am – 11:15am (CET) · Thursday, 21st October

Case study:Sanofi: Interactive and personalised video content that mimics the F2F rep experience

  • Receive, recognize and resonate: Understanding HCP needs for value-driven content
  • Mimic the rep-experience and deliver closed-loop messaging through interactive video experience that personalizes the content based on the customer profile

Esra Caliskan Digital Initiatives Manager Sanofi

11:15am – 11:30am (CET) · Thursday, 21st October

Building a Digital Content Factory to help accelerate content production for personalized customer engagement

Nataliya Andreychuk CEO Viseven

11:30am – 11:45am (CET) · Thursday, 21st October

Case study:How to optimise your email campaigns and create ultra-qualified outreach for reps

  • How to use your modular content system to optimise email creation and delivery. Hear the agile and iteratives processes needed to deliver engaging emails in a saturated market.
  • Unlock your CRM potential by giving the reps the tools to meet customer expectations without dictating their reach out. Options over coercion!

Andreas Dach Digital & Multi-Channel Lead, ASG Eli Lilly

11:45am – 12:00pm (CET) · Thursday, 21st October

Live Q&A: Create value+ and personalised content for HCP engagement

  • Quiz our expert speakers on their case studies and their views on the future

Esra Caliskan Digital Initiatives Manager Sanofi

Andreas Dach Digital & Multi-Channel Lead, ASG Eli Lilly

Nataliya Andreychuk CEO Viseven

Scale new market access models: Pricing, partnership and digital innovation to ensure health equity

12:30pm – 12:45pm (CET) · Thursday, 21st October

Fireside chat:The imperative of equal access to treatment: How Bristol Myers Squibb is working to meet diverse needs across the European access market

  • Understand how differences in market authorization across Europe results in vast disparities for patient access
  • Discover All.Can, an international multi-stakeholder organisation empowering collaboration for improved outcomes in cancer care
  • Learn how BMS is working to make Opdivo available in the West Balkans region

Ester Banque SVP and Head, Intercontinental Bristol Myers Squibb

12:45pm – 1:30pm (CET) · Thursday, 21st October

Panel:The digital disruption of market access

  • Understand how integrated digital healthcare ecosystems are driving the future of payer relationships and collaboration
  • Discover how the digital transformation is reshaping access, from value propositions to healthcare delivery
  • Build the capabilities needed to leverage digital innovation, from data management and AI to evidence generation, digital adaptative dossiers and stakeholder interactions

Raquel Riol Head, Market Access AMESA region Sanofi

Adam Kundewicz Head, Global Strategic Market Access Initiatives Boehringer Ingelheim

Clare Hague Senior Director, Therapy Area Market Access Leader, Hematology Janssen

1:30pm – 1:45pm (CET) · Thursday, 21st October

Fireside chat: Collaboration as the key to accelerating the new market access model

  • Discover why a new approach to market access is needed in a post-pandemic world
  • Turn innovation into value for patients – how Astellas is bridging the gap
  • Why aligning stakeholders around the value of patient insights is key

Jackie Williams General Manager, UK Astellas

1:45pm – 2:00pm (CET) · Thursday, 21st October

Sponsored Thought Leadership Opportunity

  • For more information, reach out to Maddie Sheard, Director of Business Development

2:00pm – 2:15pm (CET) · Thursday, 21st October

Case study:Entresto. How a patient-centric global mindset drove regulatory innovation and accelerated approval and reimbursement

  • Discover how Novartis Albania utilised FDA approvals to become the second country in Europe to register Entresto, fast-tracking beyond the EMA
  • Understand how to use patient engagement and public health campaigns to accelerate reimbursement
  • Learn how the multilateral success of Entresto has shaped the culture of access in Novartis Albania, driving the adoption of greater multifunctional collaboration and shaping patient engagement strategies

Melissa Troshani Head, Patient Access Public Affairs Novartis

2:15pm – 2:30pm (CET) · Thursday, 21st October

Live Q&A: Scale new market access models: Pricing, partnership and digital innovation to ensure health equity

  • Quiz our expert speakers on their case studies and their views on the future

Jackie Williams General Manager, UK Astellas

Melissa Troshani Head, Patient Access Public Affairs Novartis